Our goal is to assist scientists whose research may be relevant to drug discovery and/or development in framing their research report in such a way that their findings are appropriately placed within the drug discovery and development process, thereby facilitating the effective translation of preclinical research to humans. . One of the key topics of our conference is that the approach is lengthy, convoluted, and expensive enough that for any new medication to be authorized for clinical usage, several physiological sites must be studied, and new scientific methods may be necessary to investigate each new target. The efficiency of the development process can be improved by studies that contribute to the resolution of any of the many scientific and operational difficulties that arise during the process. Being aware of these challenges enables for the early introduction of actions that will improve the chances of success.

Submission Guidelines

The International Conference invites abstracts from delegates of all over the globe including guest/ invited speakers, faculties, research scholars, post graduate and graduate students from different organizations. This conference will be suitable forum for sharing views on drug discovery & development, role of pharmacovigilance and future challenges in this field. Abstracts up to 250-300 words should be prepared using Times New Roman (12pt), in single line. Title should be in bold. The abstract should be free from plagiarism. Mention names of the author(s), affiliation(s), and mail id of the corresponding author. Underline the name of presenting author and email to iccppdd@kalingauniversity.ac.in.

Papers are to be submitted in the form of manuscript as per the journal author guidelines provided in the website of the journal. Plagiarised free papers should be mailed to iccppdd@kalingauniversity.ac.in within the deadline. All the selected papers will be published in SCOPUS indexed journal or UGC CARE I approved journal. Article Processing Charges will be as per the selected journal and the publication charge will be completely paid by author

List of Topics

• Thematic areas Post-marketing safety surveillance
• Pharmacovigilance
• Safety regulatory submissions
• Pharmacoeconomics
• Adverse drug reactions
• Cardiovascular Medicine
• Drug utilization research
• Patient care
• Pharmaceutical care
• Emergent drug development process
• Nanotherapeutics safety parameters
• Life Sciences & allied health sciences
• Biotechnological benefits
• Pharmacovigilance & Clinical trial strategy
• Clinical/medical case studies
• Unreported adverse interactions
• Emerging diseases
• Adjunctive pharmacology
• Pharmaceutical sciences
• Adverse drug reaction monitoring

Committees

Program Committee

ORGANIZING COMMITTEE

Chief Patrons

Dr. Rajeev Kumar Chairman, Kalinga University , Naya Raipur, India

Dr. Sandeep Arora Chancellor, Kalinga University, Naya Raipur, India

Patrons

Dr. R. Sridhar Vice Chancellor, Kalinga University, Naya Raipur, India

Dr. Byju John Director General, Kalinga University, Naya Raipur, India

Dr. Sandeep Gandhi Registrar, Kalinga University, Naya Raipur, India

Mr. Rahul Mishra Dean Academic Affairs, Kalinga University, Naya Raipur, India

Ms. Lincy Roy Deputy Registrar, HR Head, Kalinga University, Naya Raipur, India

Organizing committee

Conveners

Dr. Sandip Prasad Tiwari Principal, Faculty of Pharmacy, Kalinga University, Naya Raipur

Chairman, Adverse Drug Reaction Monitoring Center, Faculty of Pharmacy, Kalinga University, Naya Raipur, India

Contact no: 91-9907824851

Email id: sandip.tiwari@kalingauniversity.ac.in

Ms. Rajni Yadav Assistant Professor Co-ordinator, Adverse Drug Reaction Monitoring Center, Faculty of Pharmacy, Kalinga University, Naya Raipur, India

Contact no: 91-9144760746 Email id: rajni.yadav@kalingauniversity.ac.in

Co-Conveners

Mr. Sudeep Mandal Assistant Professor, Faculty of Pharmacy, Kalinga University, Naya Raipur, India

Contact no: 91-8770084673 Email id: sudeep.mandal@kalingauniversity.ac.in

Mr. Deependra Soni Assistant Professor, Faculty of Pharmacy, Kalinga University, Naya Raipur, India

Dr. Bhumika Chandrakar Assistant Professor Deputy Co-ordinator, Adverse Drug Reaction Monitoring Center, Faculty of Pharmacy, Kalinga University, Naya Raipur, India

Invited Speakers

• Dr Jai Prakash Senior Principal Scientific Officer & Officer-in-Charge National Coordination Centre Pharmacovigilance Programme of India Indian Pharmacopoeia Commission, Ghaziabad, Uttar Pradesh, India
• Dr. Maya Sharma Medical Director, Win Medicare, Modi Mundi Pharma, Signutra, India
• Ms. Katherine Daneri Pharmacovigilance Manager, Vigilantia Healthcare, New Jersey, New York
• Ms. Giset Lopez Pharmacovigilance Specialist, CECME, Cuba
• Dr. Paul Perez Vasquez President, Peruvian Society of Pharmacovigilance (SOPERFAR), Peru
• Dr. Amer Ahmed Syed Associate Director, Pharmacovigilance, Clinical Development programs, Rocket Pharmaceuticals, Inc., USA
• Dr. B Mamtha Nair Director, Aggregate reports, Pfizer, India
• Dr. Chinmaya Mahapatra Founder President, Global Pharmacovigilance Society, India
• Dr. Irene R Fermonte Chair person, ERANIM, Israel
• Ms. Denise Rodrigues de Lima Dr. Rishi Jain Dr. Sandip Prasad Tiwari Dr. R. Shridhar Manager, Ultragenyx Pharmaceutical Inc, Brazil
• Mr. Anandarup Dutta Vice President & Head, R&D formulation, Bliss GVS Pharma Ltd., India
• Dr. Rishi Jain, Director, Medical Affairs and Pharmacovigilance at AbbVie, India
• Dr. Sandip Prasad Tiwari, Principal, Faculty of Pharmacy, Kalinga University
• Dr. R. Shridhar, Vice Chancellor, Kalinga University, Raipur
•  

Publication

The selected full-length paper will be published in UGC approved or SCOPUS indexed journal. All the abstracts will be published in the form of conference proceedings. Soft copy of conference proceedings will be provided to all participants

Venue

The conference will be held in Auditorium, Kalinga University Campus, Kotni , Near Mantralaya, Raipur, 492101.

Contact

All questions about submissions should be emailed to iccppdd@kalingauniversity.ac.in